
Samer Al Hadidi/LinkedIn
May 18, 2025, 03:45
Samer Al Hadidi: The Potential Approval for Daratumumab in smoldering Multiple Myeloma Smoldering Myeloma
Samer Al Hadidi, Associate Professor at UAMS – University of Arkansas for Medical Sciences, shared a post on X:
“An U.S. FDA ODAC will be held May 20th to discuss the potential approval for Daratumumab in smoldering Multiple Myeloma – Smoldering Myeloma.
Very good points made in the discussion.
Few important observations summarised here.”
More posts featuring Samer Al Hadidi.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 18, 2025, 03:31
May 17, 2025, 21:36
May 17, 2025, 20:45
May 17, 2025, 20:13
May 17, 2025, 19:44